Monopar Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Monopar Therapeutics has a total shareholder equity of $4.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $6.1M and $1.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$6.02m |
| Equity | US$4.95m |
| Total liabilities | US$1.12m |
| Total assets | US$6.07m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1IY0's short term assets ($6.1M) exceed its short term liabilities ($1.1M).
Long Term Liabilities: 1IY0 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 1IY0 is debt free.
Reducing Debt: 1IY0 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1IY0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 1IY0 is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.